Emma A. Gordon

904 total citations · 1 hit paper
7 papers, 643 citations indexed

About

Emma A. Gordon is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Emma A. Gordon has authored 7 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Infectious Diseases and 1 paper in Organic Chemistry. Recurrent topics in Emma A. Gordon's work include Gut microbiota and health (2 papers), Genomics and Phylogenetic Studies (2 papers) and SARS-CoV-2 and COVID-19 Research (1 paper). Emma A. Gordon is often cited by papers focused on Gut microbiota and health (2 papers), Genomics and Phylogenetic Studies (2 papers) and SARS-CoV-2 and COVID-19 Research (1 paper). Emma A. Gordon collaborates with scholars based in United States, France and Canada. Emma A. Gordon's co-authors include Sean F. Brady, John Chu, Louis Cohen, Xavier Vila‐Farrés, Boojala Vijay B. Reddy, Melinda A. Ternei, Aneta Rogoz, Christophe Lemetre, Paula Y. Calle and J. Kipchirchir Bitok and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Immunology.

In The Last Decade

Emma A. Gordon

7 papers receiving 629 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Commensal bacteria make GPCR ligands that mimic human signalling molecules

2017 349 citations Louis Cohen, Daria Esterházy et al. Nature profile →

Peers

Countries citing papers authored by Emma A. Gordon

Since Specialization

Citations

This map shows the geographic impact of Emma A. Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma A. Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma A. Gordon more than expected).

Fields of papers citing papers by Emma A. Gordon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma A. Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma A. Gordon. The network helps show where Emma A. Gordon may publish in the future.

Co-authorship network of co-authors of Emma A. Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of Emma A. Gordon. A scholar is included among the top collaborators of Emma A. Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma A. Gordon. Emma A. Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	PET‐RAFT Polymerization of Star Polymers with Folded ortho‐Phenylene Cores 2023 ·Macromolecular Rapid Communications ·Kate G. E. Bradford, (unknown), Emma A. Gordon, C. Scott Hartley, Dominik Konkolewicz	3
2	Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with Molecular Adjuvant Adenosine Deaminase-1 2022 ·The Journal of Immunology ·Gina Cusimano, E. Gary, Matthew R. Bell, Bryce M. Warner, Jennifer Connors, Nicholas J. Tursi, Ali Ali, (unknown), Gabriela Canziani, (unknown), Emma A. Gordon, Irwin Chaiken, Sarah K. Wootton, Trevor R.F. Smith, Stephanie Ramos, Darwyn Kobasa, David B. Weiner, Michele A. Kutzler, Elias K. Haddad	3
3	Pre-vaccination frequency of circulatory Tfh is associated with robust immune response to TV003 dengue vaccine 2022 ·PLoS Pathogens ·Abdullah M. Izmirly, (unknown), Jennifer Connors, (unknown), (unknown), Emma A. Gordon, (unknown), Joshua Chang Mell, Gokul Swaminathan, (unknown), Michele A. Kutzler, Esper G. Kallás, Rafick‐Pierre Sékaly, Elias K. Haddad	5
4	Beyond the pan-genome: current perspectives on the functional and practical outcomes of the distributed genome hypothesis 2020 ·Biochemical Society Transactions ·(unknown), Emma A. Gordon, (unknown), Joshua Chang Mell, Garth D. Ehrlich	5
5	Commensal bacteria make GPCR ligands that mimic human signalling molecules breakdown → 2017 ·Nature ·Louis Cohen, Daria Esterházy, Seong-Hwan Kim, Christophe Lemetre, Rhiannon R. Aguilar, Emma A. Gordon, Amanda J. Pickard, Justin R. Cross, Ana B. Emiliano, Sun M. Han, John Chu, Xavier Vila‐Farrés, (unknown), Aneta Rogoz, Paula Y. Calle, Craig P. Hunter, J. Kipchirchir Bitok, Sean F. Brady	349
6	Discovery of MRSA active antibiotics using primary sequence from the human microbiome 2016 ·Nature Chemical Biology ·John Chu, Xavier Vila‐Farrés, Daigo Inoyama, Melinda A. Ternei, Louis Cohen, Emma A. Gordon, Boojala Vijay B. Reddy, Zachary Charlop–Powers, Henry Zebroski, Ricardo Gallardo‐Macias, (unknown), (unknown), Steven Park, David S. Perlin, Joel S. Freundlich, Sean F. Brady	139
7	Functional metagenomic discovery of bacterial effectors in the human microbiome and isolation of commendamide, a GPCR G2A/132 agonist 2015 ·Proceedings of the National Academy of Sciences ·Louis Cohen, Hahk‐Soo Kang, John Chu, Yun-Han Huang, Emma A. Gordon, Boojala Vijay B. Reddy, Melinda A. Ternei, Jeffrey W. Craig, Sean F. Brady	139

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact